APO Research
Talk to an analyst

APO RESEARCH · REPORT

Head-mounted Neuromodulation Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Head-mounted Neuromodulation Device Market Outlook and Growth Opportunities 2026

29 December 2025192 pages

Choose your research edition.

Industry ResearchHead-mounted Neuromodulation Device Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Head-mounted Neuromodulation Device Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Head-mounted Neuromodulation Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Head-mounted Neuromodulation Device Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Head-mounted Neuromodulation Device Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Head-mounted Neuromodulation Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Head-mounted Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Head-mounted Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Head-mounted Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Head-mounted Neuromodulation Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Head-mounted Neuromodulation Device market include Brainco, NeuroSky, Muse and Halo Neuroscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Head-mounted Neuromodulation Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Head-mounted Neuromodulation Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Head-mounted Neuromodulation Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Head-mounted Neuromodulation Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Head-mounted Neuromodulation Device Segment by Company

Brainco

NeuroSky

Muse

Halo Neuroscience

Head-mounted Neuromodulation Device Segment by Type

Headphones

Headbands

Others

Head-mounted Neuromodulation Device Segment by Application

Adults

Children

Head-mounted Neuromodulation Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Head-mounted Neuromodulation Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Head-mounted Neuromodulation Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Head-mounted Neuromodulation Device significant trends, drivers, influence factors in global and regions.

6. To analyze Head-mounted Neuromodulation Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Head-mounted Neuromodulation Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Head-mounted Neuromodulation Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Head-mounted Neuromodulation Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Head-mounted Neuromodulation Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Head-mounted Neuromodulation Device industry.

Chapter 3: Detailed analysis of Head-mounted Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Head-mounted Neuromodulation Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Head-mounted Neuromodulation Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Head-mounted Neuromodulation Device Industry Trends Table 2. Head-mounted Neuromodulation Device Industry Drivers Table 3. Head-mounted Neuromodulation Device Industry Opportunities and Challenges Table 4. Head-mounted Neuromodulation Device Industry Restraints Table 5. Global Head-mounted Neuromodulation Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Head-mounted Neuromodulation Device Revenue Share by Company (2021-2026) Table 7. Global Head-mounted Neuromodulation Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Head-mounted Neuromodulation Device Sales Volume Share by Company (2021-2026) Table 9. Global Head-mounted Neuromodulation Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Head-mounted Neuromodulation Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Head-mounted Neuromodulation Device Key Company Manufacturing Base & Headquarters Table 12. Global Head-mounted Neuromodulation Device Company, Product Type & Application Table 13. Global Head-mounted Neuromodulation Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Head-mounted Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Headphones Table 18. Significant Companies of Headbands Table 19. Significant Companies of Others Table 20. Global Head-mounted Neuromodulation Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Head-mounted Neuromodulation Device Sales Volume by Type (2021-2026) & (k units) Table 22. Global Head-mounted Neuromodulation Device Sales Volume by Type (2027-2032) & (k units) Table 23. Global Head-mounted Neuromodulation Device Sales Volume Share by Type (2021-2026) Table 24. Global Head-mounted Neuromodulation Device Sales Volume Share by Type (2027-2032) Table 25. Global Head-mounted Neuromodulation Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Head-mounted Neuromodulation Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Head-mounted Neuromodulation Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Head-mounted Neuromodulation Device Sales Value Share by Type (2021-2026) Table 29. Global Head-mounted Neuromodulation Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Adults Table 31. Significant Companies of Children Table 32. Global Head-mounted Neuromodulation Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Head-mounted Neuromodulation Device Sales Volume by Application (2021-2026) & (k units) Table 34. Global Head-mounted Neuromodulation Device Sales Volume by Application (2027-2032) & (k units) Table 35. Global Head-mounted Neuromodulation Device Sales Volume Share by Application (2021-2026) Table 36. Global Head-mounted Neuromodulation Device Sales Volume Share by Application (2027-2032) Table 37. Global Head-mounted Neuromodulation Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Head-mounted Neuromodulation Device Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Head-mounted Neuromodulation Device Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Head-mounted Neuromodulation Device Sales Value Share by Application (2021-2026) Table 41. Global Head-mounted Neuromodulation Device Sales Value Share by Application (2027-2032) Table 42. Global Head-mounted Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Head-mounted Neuromodulation Device Sales by Region (2021-2026) & (k units) Table 44. Global Head-mounted Neuromodulation Device Sales Market Share by Region (2021-2026) Table 45. Global Head-mounted Neuromodulation Device Sales by Region (2027-2032) & (k units) Table 46. Global Head-mounted Neuromodulation Device Sales Market Share by Region (2027-2032) Table 47. Global Head-mounted Neuromodulation Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Head-mounted Neuromodulation Device Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Head-mounted Neuromodulation Device Sales Value Share by Region (2021-2026) Table 50. Global Head-mounted Neuromodulation Device Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Head-mounted Neuromodulation Device Sales Value Share by Region (2027-2032) Table 52. Global Head-mounted Neuromodulation Device Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Head-mounted Neuromodulation Device Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Head-mounted Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Head-mounted Neuromodulation Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Head-mounted Neuromodulation Device Sales by Country (2021-2026) & (k units) Table 57. Global Head-mounted Neuromodulation Device Sales Market Share by Country (2021-2026) Table 58. Global Head-mounted Neuromodulation Device Sales by Country (2027-2032) & (k units) Table 59. Global Head-mounted Neuromodulation Device Sales Market Share by Country (2027-2032) Table 60. Global Head-mounted Neuromodulation Device Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Head-mounted Neuromodulation Device Sales Value Market Share by Country (2021-2026) Table 62. Global Head-mounted Neuromodulation Device Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Head-mounted Neuromodulation Device Sales Value Market Share by Country (2027-2032) Table 64. Brainco Company Information Table 65. Brainco Business Overview Table 66. Brainco Head-mounted Neuromodulation Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Brainco Head-mounted Neuromodulation Device Product Portfolio Table 68. Brainco Recent Development Table 69. NeuroSky Company Information Table 70. NeuroSky Business Overview Table 71. NeuroSky Head-mounted Neuromodulation Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. NeuroSky Head-mounted Neuromodulation Device Product Portfolio Table 73. NeuroSky Recent Development Table 74. Muse Company Information Table 75. Muse Business Overview Table 76. Muse Head-mounted Neuromodulation Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Muse Head-mounted Neuromodulation Device Product Portfolio Table 78. Muse Recent Development Table 79. Halo Neuroscience Company Information Table 80. Halo Neuroscience Business Overview Table 81. Halo Neuroscience Head-mounted Neuromodulation Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Halo Neuroscience Head-mounted Neuromodulation Device Product Portfolio Table 83. Halo Neuroscience Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Head-mounted Neuromodulation Device Distributors List Table 87. Head-mounted Neuromodulation Device Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Head-mounted Neuromodulation Device Product Image Figure 2. Global Head-mounted Neuromodulation Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Head-mounted Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Head-mounted Neuromodulation Device Sales (2021-2032) & (k units) Figure 5. Global Head-mounted Neuromodulation Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Head-mounted Neuromodulation Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Headphones Image Figure 10. Headbands Image Figure 11. Others Image Figure 12. Global Head-mounted Neuromodulation Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Head-mounted Neuromodulation Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Head-mounted Neuromodulation Device Sales Volume Share by Type (2021-2032) Figure 15. Global Head-mounted Neuromodulation Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Head-mounted Neuromodulation Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Head-mounted Neuromodulation Device Sales Value Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Children Image Figure 20. Global Head-mounted Neuromodulation Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Head-mounted Neuromodulation Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Head-mounted Neuromodulation Device Sales Volume Share by Application (2021-2032) Figure 23. Global Head-mounted Neuromodulation Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Head-mounted Neuromodulation Device Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Head-mounted Neuromodulation Device Sales Value Share by Application (2021-2032) Figure 26. Global Head-mounted Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Head-mounted Neuromodulation Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Head-mounted Neuromodulation Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Head-mounted Neuromodulation Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Head-mounted Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 31. North America Head-mounted Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Head-mounted Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Head-mounted Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Head-mounted Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Head-mounted Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Head-mounted Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 37. South America Head-mounted Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Head-mounted Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Head-mounted Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Head-mounted Neuromodulation Device Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Head-mounted Neuromodulation Device Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Headphones
  • Headbands
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Brainco
  • NeuroSky
  • Muse
  • Halo Neuroscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Head-mounted Neuromodulation Device Sales Value (2021-2032)
  4. 1.2.2 Global Head-mounted Neuromodulation Device Sales Volume (2021-2032)
  5. 1.2.3 Global Head-mounted Neuromodulation Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Head-mounted Neuromodulation Device Market Dynamics
  1. 2.1 Head-mounted Neuromodulation Device Industry Trends
  2. 2.2 Head-mounted Neuromodulation Device Industry Drivers
  3. 2.3 Head-mounted Neuromodulation Device Industry Opportunities and Challenges
  4. 2.4 Head-mounted Neuromodulation Device Industry Restraints
3 Head-mounted Neuromodulation Device Market by Company
  1. 3.1 Global Head-mounted Neuromodulation Device Company Revenue Ranking in 2025
  2. 3.2 Global Head-mounted Neuromodulation Device Revenue by Company (2021-2026)
  3. 3.3 Global Head-mounted Neuromodulation Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Head-mounted Neuromodulation Device Average Price by Company (2021-2026)
  5. 3.5 Global Head-mounted Neuromodulation Device Company Ranking (2024-2026)
  6. 3.6 Global Head-mounted Neuromodulation Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Head-mounted Neuromodulation Device Company Product Type and Application
  8. 3.8 Global Head-mounted Neuromodulation Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Head-mounted Neuromodulation Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Head-mounted Neuromodulation Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Head-mounted Neuromodulation Device Market by Type
  1. 4.1 Head-mounted Neuromodulation Device Type Introduction
  2. 4.1.1 Headphones
  3. 4.1.2 Headbands
  4. 4.1.3 Others
  5. 4.2 Global Head-mounted Neuromodulation Device Sales Volume by Type
  6. 4.2.1 Global Head-mounted Neuromodulation Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Head-mounted Neuromodulation Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Head-mounted Neuromodulation Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Head-mounted Neuromodulation Device Sales Value by Type
  10. 4.3.1 Global Head-mounted Neuromodulation Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Head-mounted Neuromodulation Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Head-mounted Neuromodulation Device Sales Value Share by Type (2021-2032)
5 Head-mounted Neuromodulation Device Market by Application
  1. 5.1 Head-mounted Neuromodulation Device Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Head-mounted Neuromodulation Device Sales Volume by Application
  5. 5.2.1 Global Head-mounted Neuromodulation Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Head-mounted Neuromodulation Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Head-mounted Neuromodulation Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Head-mounted Neuromodulation Device Sales Value by Application
  9. 5.3.1 Global Head-mounted Neuromodulation Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Head-mounted Neuromodulation Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Head-mounted Neuromodulation Device Sales Value Share by Application (2021-2032)
6 Head-mounted Neuromodulation Device Regional Sales and Value Analysis
  1. 6.1 Global Head-mounted Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Head-mounted Neuromodulation Device Sales by Region (2021-2032)
  3. 6.2.1 Global Head-mounted Neuromodulation Device Sales by Region: 2021-2026
  4. 6.2.2 Global Head-mounted Neuromodulation Device Sales by Region (2027-2032)
  5. 6.3 Global Head-mounted Neuromodulation Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Head-mounted Neuromodulation Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Head-mounted Neuromodulation Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Head-mounted Neuromodulation Device Sales Value by Region (2027-2032)
  9. 6.5 Global Head-mounted Neuromodulation Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Head-mounted Neuromodulation Device Sales Value (2021-2032)
  12. 6.6.2 North America Head-mounted Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Head-mounted Neuromodulation Device Sales Value (2021-2032)
  15. 6.7.2 Europe Head-mounted Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Head-mounted Neuromodulation Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Head-mounted Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Head-mounted Neuromodulation Device Sales Value (2021-2032)
  21. 6.9.2 South America Head-mounted Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Head-mounted Neuromodulation Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Head-mounted Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
7 Head-mounted Neuromodulation Device Country-level Sales and Value Analysis
  1. 7.1 Global Head-mounted Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Head-mounted Neuromodulation Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Head-mounted Neuromodulation Device Sales by Country (2021-2032)
  4. 7.3.1 Global Head-mounted Neuromodulation Device Sales by Country (2021-2026)
  5. 7.3.2 Global Head-mounted Neuromodulation Device Sales by Country (2027-2032)
  6. 7.4 Global Head-mounted Neuromodulation Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Head-mounted Neuromodulation Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Head-mounted Neuromodulation Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Head-mounted Neuromodulation Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Head-mounted Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Head-mounted Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Brainco
  2. 8.1.1 Brainco Company Information
  3. 8.1.2 Brainco Business Overview
  4. 8.1.3 Brainco Head-mounted Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Brainco Head-mounted Neuromodulation Device Product Portfolio
  6. 8.1.5 Brainco Recent Developments
  7. 8.2 NeuroSky
  8. 8.2.1 NeuroSky Company Information
  9. 8.2.2 NeuroSky Business Overview
  10. 8.2.3 NeuroSky Head-mounted Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 NeuroSky Head-mounted Neuromodulation Device Product Portfolio
  12. 8.2.5 NeuroSky Recent Developments
  13. 8.3 Muse
  14. 8.3.1 Muse Company Information
  15. 8.3.2 Muse Business Overview
  16. 8.3.3 Muse Head-mounted Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Muse Head-mounted Neuromodulation Device Product Portfolio
  18. 8.3.5 Muse Recent Developments
  19. 8.4 Halo Neuroscience
  20. 8.4.1 Halo Neuroscience Company Information
  21. 8.4.2 Halo Neuroscience Business Overview
  22. 8.4.3 Halo Neuroscience Head-mounted Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Halo Neuroscience Head-mounted Neuromodulation Device Product Portfolio
  24. 8.4.5 Halo Neuroscience Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Head-mounted Neuromodulation Device Value Chain Analysis
  2. 9.1.1 Head-mounted Neuromodulation Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Head-mounted Neuromodulation Device Sales Mode & Process
  6. 9.2 Head-mounted Neuromodulation Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Head-mounted Neuromodulation Device Distributors
  9. 9.2.3 Head-mounted Neuromodulation Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst